SCHEMBL8377392

SCHEMBL8377392

CC(C)c1c(OCCN(C=O)OC(C)(C)C)noc1-c1ccc(Cl)cc1Cl

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 4/20 0.33
PPARA Q07869 2/20 0.31
PPARG P37231 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8377411 0.89 TSHR (0.31) PPARD
SCHEMBL8376446 0.87 MAPT (0.31)
SCHEMBL8377387 0.83 KCNH2 (0.30)
SCHEMBL8375679 0.79 NPC1 (0.31)
SCHEMBL8375800 0.78 ALDH1A1 (0.33)
SCHEMBL8376904 0.78 ALOX15 (0.36) PPARD
SCHEMBL5617576 0.78 DPP4 (0.36) PPARDPPARA
Hydrochloric Acid SCHEMBL8375807 0.77 DPP4 (0.36) PPARDPPARA
SCHEMBL8378808 0.77 CHRNB2 (0.33)
SCHEMBL8377390 0.76 IDO1 (0.46) PPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6005116-A HAVE INHIBITION ACTIVITIES AGAINST TYPE A-MONOAMINE OXIDASE; TREATING OR PREVENTING DEPRESSION, PARKINSON'S DISEASE, ALZEHEIMER'S DEMENTIA, OR CEREBROVASCULAR DEMENTIA SANKYO COMPANY, LIMITED (JP) 1999-12-21 US disclosed
EP-0885891-A1 ISOXAZOLE DERIVATIVES SANKYO COMPANY LIMITED (JP) 1998-12-23 EP disclosed